Karyotype abnormalities | Therapy | Cause of death |
---|---|---|
+ 8 | DAC | Sepsis after induction therapy |
Normal | DAC, consolidation, AlloHSCT | GvHD, infection complications |
Unknown | DAC | Sepsis after induction therapy |
Unknown | CLAG | Refractoriness on therapy |
Inv(16) | DAC, consolidation | Alive |
Complex changes | CLAG | Refractoriness on therapy |
Normal | DAC, consolidation | Relapse |
t(8;21) | DAC, consolidation | Alive |
-Y | DAC, consolidation | Aspergillosis |
Complex changes | DAC, CLAG-M, consolidation, AlloHSCT | Relapse |
Normal | DAC, consolidation, AlloHSCT | Relapse |
Complex changes | DAC, consolidation, AlloHSCT | Relapse |
Normal | DAC, CLAG-M | Refractoriness on therapy, aspergillosis |
Normal | DAC, Consolidation, AlloHSCT | Relapse |